Patents by Inventor Isabelle Carlavan

Isabelle Carlavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of SC4MOL for treating acne or hyperseborrhea
    Publication number: 20100021892
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of sterol-C4-methyl oxidase (SC4MOL), and the use of modulators of the expression or activity of this enzyme for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: January 28, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Mohamed El-Alfy, Van Luu-The, Ezequiel L. Calvo, Jerome Aubert, Isabelle Carlavan, Sophie Deret, Johannes Voegel
  • Modulators of the transporter ABCD3 for treating acne or hyperseborrhea
    Publication number: 20090258356
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of the peroxisome membrane transporter 1 comprising a type 3 ATP-binding site of the sub-family D (ABCD3), and the use of modulators of the expression or activity of this transporter for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: October 15, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Mohamed El-Alfy, Ezequiel L. Calvo, Isabelle Carlavan, Pascal Collette, Sophie Deret, Michel Rivier
  • Modulators of scarb-1 for treating acne or hyperseborrhea
    Publication number: 20090246776
    Abstract: An in vitro method for screening candidate compounds for the preventive or curative treatment of acne, includes the determination of the capacity of a compound to modulate the expression or the activity of the SCARB-1 receptor, and the use of modulators of the expression or activity of this receptor for the treatment of acne or skin disorders associated with a hyperseborrhea; methods for the in vitro diagnosis or prognosis of these pathologies are also described.
    Type: Application
    Filed: January 21, 2009
    Publication date: October 1, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Fernand Labrie, Isabelle Carlavan, Pascal Collette, Ezequiel L. Calvo, Jerome Aubert, Johannes Voegel
  • Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20060052627
    Abstract: Novel compounds which modulate PPAR-type receptors have the following general formula (I): and are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology and in the fields of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or are formulated into cosmetic compositions.
    Type: Application
    Filed: August 12, 2005
    Publication date: March 9, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Etienne Thoreau, Isabelle Carlavan, Pascale Mauvais, Johannes Voegel
  • Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20060035969
    Abstract: Novel compounds which modulate PPAR-type receptors have the following general formula (I): and are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology and in the fields of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or are formulated into cosmetic compositions.
    Type: Application
    Filed: August 12, 2005
    Publication date: February 16, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Etienne Thoreau, Isabelle Carlavan, Pascale Mauvais, Johannes Voegel